Loading organizations...
§ Private Profile · Cambridge, Cambridgeshire, United Kingdom
Chemical technology company developing microcapsules for consumer goods and industrial sectors, focused on odor elimination.
Based in Cambridge, England, Aqdot is a chemical technology company that develops and manufactures energy-efficient microcapsules using supramolecular chemistry for the controlled capture and release of molecules. The enterprise licenses its proprietary technology and supplies chemical formulations, such as its core AqFresh platform, to multinational manufacturers across the household care, automotive, textile, and pharmaceutical sectors. Operating with a portfolio of thirteen filed patents, the company has raised over sixteen million dollars in total venture funding from institutional investors including IP Group, Parkwalk Advisors, and BGF. To scale its commercial operations, the business recently partnered with Menadiona in Spain to expand its AqFresh manufacturing capacity to five hundred tonnes annually. The company was founded in 2012 as a spin-out from the University of Cambridge by academic founders Chris Abell, Oren Scherman, Jing Zhang, and Roger Coulston.
Aqdot has raised $7.2M across 1 funding round.
Aqdot has raised $7.2M in total across 1 funding round.
Aqdot has raised $7.2M across 1 funding round. Most recently, it raised $7.2M Series A in February 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 9, 2016 | $7.2M Series A | Kelsey Lynn | Cambridge Enterprise, Parkwalk Advisors, Providence Investment Company | Announced |
Aqdot has raised $7.2M in total across 1 funding round.
Aqdot's investors include Kelsey Lynn, Cambridge Enterprise, Parkwalk Advisors, Providence Investment Company.